Cary Street Partners’s Labcorp LH Stock Holding History

Cary Street Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.09M	Sell	14,623 -143	-1%	-$37.6K	0.09%	228
2026 Q1	$3.94M	Buy	14,766 +2	+0%	+$542	0.1%	216
2025 Q4	$3.7M	Sell	14,764 -1,030	-7%	-$274K	0.09%	223
2025 Q3	$4.53M	Sell	15,794 -276	-2%	-$73.9K	0.12%	186
2025 Q2	$4.22M	Sell	16,070 -21	-0.1%	-$5.11K	0.12%	189
2025 Q1	$3.74M	Sell	16,091 -263	-2%	-$63.8K	0.12%	180
2024 Q4	$3.75M	Buy	+16,354	New	+$3.75M	0.12%	167

Other funds holding LH

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

JIC

Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

DIA

Davidson Investment Advisors Great Falls, Montana $2.45B AUM 21.8% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

DDPIC

Deroy & Devereaux Private Investment Counsel Bloomfield Hills, Michigan $2.4B AUM 57.66% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

MCM

McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return

Cary Street Partners's LH Position: Q2 2026 in Review

Cary Street Partners reduced its Labcorp (LH) stake by 0.97% in Q2 2026, selling an estimated $37.6K and leaving 14,623 shares worth $4.09M. The position accounts for 0.09% of the portfolio, ranked #228.

Cary Street Partners first reported a position in LH in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.53M in Q3 2025. 319 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Cary Street Partners held 14,623 shares of Labcorp worth $4.09M as of Q2 2026.
Cary Street Partners sold 143 Labcorp shares in Q2 2026, an estimated $37.6K.
Labcorp made up 0.09% of Cary Street Partners's portfolio in Q2 2026, its #228 holding.
Cary Street Partners first reported a position in Labcorp in Q4 2024 and has held it in 7 quarters since.
Cary Street Partners's Labcorp position peaked at $4.53M in Q3 2025.
319 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.